These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 15310330
1. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis. Karaarslan A, Arikan S, Ozcan M, Ozcan KM. Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330 [Abstract] [Full Text] [Related]
2. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Kaya AD, Kiraz N. Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704 [Abstract] [Full Text] [Related]
3. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method]. Carrillo-Muñoz AJ, Quindós G, Ruesga M, Brió S, del Valle O, Rodríguez V, Hernández-Molina JM, Cantón E, Pemán J, Santos P. Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450 [Abstract] [Full Text] [Related]
4. In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens. Yenişehirli G, Bulut Y, Güven M, Günday E. J Laryngol Otol; 2009 Sep; 123(9):978-81. PubMed ID: 19454132 [Abstract] [Full Text] [Related]
5. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium. Sarifakioglu E, Seçkin D, Demirbilek M, Can F. Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532 [Abstract] [Full Text] [Related]
6. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis. Carrillo-Muñoz AJ, Giusiano G, Cárdenes D, Hernández-Molina JM, Eraso E, Quindós G, Guardia C, del Valle O, Tur-Tur C, Guarro J. Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383 [Abstract] [Full Text] [Related]
7. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Li L, Wang Z, Li R, Luo S, Sun X. Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669 [Abstract] [Full Text] [Related]
8. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. Martín-Mazuelos E, Pemán J, Valverde A, Chaves M, Serrano MC, Cantón E. J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236 [Abstract] [Full Text] [Related]
9. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp. Dannaoui E, Persat F, Monier MF, Borel E, Piens MA, Picot S. Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424 [Abstract] [Full Text] [Related]
10. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A. Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312 [Abstract] [Full Text] [Related]
11. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method. Bhatia VK, Sharma PC. Indian J Med Microbiol; 2015 Apr; 33(4):533-7. PubMed ID: 26470960 [Abstract] [Full Text] [Related]
12. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Gupta AK, Kohli Y. Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235 [Abstract] [Full Text] [Related]
13. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species. Kantarcioğlu AS, Yucel A. J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546 [Abstract] [Full Text] [Related]
14. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole. Berthet N, Faure O, Bakri A, Ambroise-Thomas P, Grillot R, Brugère JF. J Antimicrob Chemother; 2003 Jun; 51(6):1419-22. PubMed ID: 12716778 [Abstract] [Full Text] [Related]
15. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. Espinel-Ingroff A. J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057 [Abstract] [Full Text] [Related]
16. Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay. Balajee SA, Imhof A, Gribskov JL, Marr KA. J Antimicrob Chemother; 2005 Jan; 55(1):102-5. PubMed ID: 15546970 [Abstract] [Full Text] [Related]
17. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. Meletiadis J, Mouton JW, Meis JF, Bouman BA, Donnelly PJ, Verweij PE, EUROFUNG Network. J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829 [Abstract] [Full Text] [Related]
18. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases]. Gürcan S, Tikveşli M, Eryildiz C, Evci C, Ener B. Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962 [Abstract] [Full Text] [Related]
19. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B. Moore CB, Walls CM, Denning DW. Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643 [Abstract] [Full Text] [Related]
20. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Ryder NS, Leitner I. Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414 [Abstract] [Full Text] [Related] Page: [Next] [New Search]